Studies that assessed B7H3 expression with cut-offs of >1% or >10% of stained tumor cells did not support a significant association between B7H3 and reduced OS (HR = 1.59, 95% CI [0.93–2.73] and HR = 1.63, 95% CI [0.93–2.85], respectively, Figure 3B). The gene discussed is CD276; the disease is neoplasm.